These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 12444194)

  • 1. Hepatitis B e Antigen and the Risk of Hepatocellular Carcinoma.
    Geier A; Gartung C; Dietrich CG
    N Engl J Med; 2002 Nov; 347(21):1721-2; author reply 1721-2. PubMed ID: 12444194
    [No Abstract]   [Full Text] [Related]  

  • 2. Hepatitis B e Antigen--the dangerous endgame of hepatitis B.
    Liang TJ; Ghany M
    N Engl J Med; 2002 Jul; 347(3):208-10. PubMed ID: 12124411
    [No Abstract]   [Full Text] [Related]  

  • 3. Hepatitis B e antigen and the risk of hepatocellular carcinoma.
    Yang HI; Lu SN; Liaw YF; You SL; Sun CA; Wang LY; Hsiao CK; Chen PJ; Chen DS; Chen CJ;
    N Engl J Med; 2002 Jul; 347(3):168-74. PubMed ID: 12124405
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nomograms for risk of hepatocellular carcinoma in patients with chronic hepatitis B virus infection.
    Yang HI; Sherman M; Su J; Chen PJ; Liaw YF; Iloeje UH; Chen CJ
    J Clin Oncol; 2010 May; 28(14):2437-44. PubMed ID: 20368541
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The development of hepatocellular carcinoma among prospectively followed children with chronic hepatitis B virus infection.
    Wen WH; Chang MH; Hsu HY; Ni YH; Chen HL
    J Pediatr; 2004 Mar; 144(3):397-9. PubMed ID: 15001956
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepatitis B virus infection--natural history and clinical consequences.
    Ganem D; Prince AM
    N Engl J Med; 2004 Mar; 350(11):1118-29. PubMed ID: 15014185
    [No Abstract]   [Full Text] [Related]  

  • 7. Hepatitis B: liver fibrosis and hepatocellular carcinoma.
    Lok AS
    Gastroenterol Clin Biol; 2009; 33(10-11):911-5. PubMed ID: 19577871
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Epidemiology of HBV related hepatocellular carcinoma in Japan].
    Nishiguchi S; Tamori A; Kuroki T; Oka H; Tanaka T; Monna T
    Nihon Rinsho; 1995 Oct; 53 Suppl(Pt 2):673-9. PubMed ID: 12442466
    [No Abstract]   [Full Text] [Related]  

  • 9. T1653 mutation in the box alpha increases the risk of hepatocellular carcinoma in patients with chronic hepatitis B virus genotype C infection.
    Ito K; Tanaka Y; Orito E; Sugiyama M; Fujiwara K; Sugauchi F; Kato T; Tokita H; Izumi N; Kato M; Yuen MF; Lai CL; Gish RG; Ueda R; Mizokami M
    Clin Infect Dis; 2006 Jan; 42(1):1-7. PubMed ID: 16323084
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Natural history of chronic hepatitis B: extending the REVEAL study.
    Cooksley WG
    Liver Int; 2010 Sep; 30(8):1085-6. PubMed ID: 20492519
    [No Abstract]   [Full Text] [Related]  

  • 11. The natural history of chronic hepatitis B virus infection.
    McMahon BJ
    Semin Liver Dis; 2004; 24 Suppl 1():17-21. PubMed ID: 15192797
    [TBL] [Abstract][Full Text] [Related]  

  • 12. When (and When Not) to Treat Patients With HBV Infection.
    Fricker ZP; Reddy KR
    Clin Gastroenterol Hepatol; 2019 Dec; 17(13):2644-2647. PubMed ID: 31154025
    [No Abstract]   [Full Text] [Related]  

  • 13. Therapeutic strategies for chronic hepatitis B virus infection in 2008.
    Khokhar A; Afdhal NH
    Am J Med; 2008 Dec; 121(12 Suppl):S33-44. PubMed ID: 19185073
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of hepatocellular carcinoma in chronic viral B and viral C liver diseases.
    Acalovschi M
    Rom J Gastroenterol; 2003 Jun; 12(2):123-30. PubMed ID: 12853999
    [No Abstract]   [Full Text] [Related]  

  • 15. [Management of asymptomatic HBV carriers].
    Yoshida H
    Nihon Rinsho; 2004 Aug; 62 Suppl 8():238-41. PubMed ID: 15453322
    [No Abstract]   [Full Text] [Related]  

  • 16. Chronic hepatitis B in children after e antigen seroclearance: final report of a 29-year longitudinal study.
    Bortolotti F; Guido M; Bartolacci S; Cadrobbi P; Crivellaro C; Noventa F; Morsica G; Moriondo M; Gatta A
    Hepatology; 2006 Mar; 43(3):556-62. PubMed ID: 16496323
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatitis B virus infection and hepatocellular carcinoma among parous Taiwanese women: nationwide cohort study.
    Fwu CW; Chien YC; Kirk GD; Nelson KE; You SL; Kuo HS; Feinleib M; Chen CJ
    J Natl Cancer Inst; 2009 Jul; 101(14):1019-27. PubMed ID: 19535774
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatitis B viral infection: part I. Clinical features.
    Dzik WH; Alter HJ
    Am Fam Physician; 1982 Aug; 26(2):119-26. PubMed ID: 6285684
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Common clinicopathological features of the patients with chronic hepatitis B virus infection who developed hepatocellular carcinoma after seroconversion to anti-HBs--a consideration of the pathogenesis of HBV-induced hepatocellular carcinoma and a strategy to inhibit it.
    Tsuboi Y; Ohkoshi S; Yano M; Suzuki K; Tsubata SS; Ishihara K; Ichida T; Sugitani S; Shibazaki K; Aoyagi Y
    Hepatogastroenterology; 2006; 53(67):110-4. PubMed ID: 16506387
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased risk of hepatocellular carcinoma in male hepatitis B surface antigen carriers with chronic hepatitis who have detectable urinary aflatoxin metabolite M1.
    Sun Z; Lu P; Gail MH; Pee D; Zhang Q; Ming L; Wang J; Wu Y; Liu G; Wu Y; Zhu Y
    Hepatology; 1999 Aug; 30(2):379-83. PubMed ID: 10421643
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.